Navigation Links
Investor Group Files Complaint With Irish Office of the Director of Corporate Enforcement Against Named Directors of Trinity Biotech
Date:2/24/2009

KANSAS CITY, Mo., Feb. 24 /PRNewswire/ -- An investor group in Trinity Biotech plc (Nasdaq: TRIB), an Irish based developer and manufacturer of diagnostic products, has petitioned the Office of the Director of Corporate Enforcement to facilitate compliance with key company law provisions designed to permit communication between shareholders and prospective shareholders.

The petition as filed asserts that Irish-based independent directors, Peter Coyne of Allied Irish Bank, and Dr. Jim Walsh, together with Chairman and CEO, Ronan O'Caoimh have breached Irish Company Law by blocking access to information requested by shareholders wishing to convert ADRs (American Depository Receipts) to the Irish shares they represent. The investor group has requested ODCE support of a formal investigation of the above named individuals for violation of Company Law and to pursue corrective action against this illegal behavior.

Commenting on the news, Mr. Reidy stated, "We are disappointed that the current Board has disregarded not only the wishes of shareholders but its obligations to respond to shareholder requests for the calling of an EGM (Extraordinary General Meeting). We are particularly displeased by the board's refusal to provide periodic notification of changes in registered ownership of company shares, which we view as a basic right protected under Irish securities law."

Contact: Tom Reidy, 816-260-8476, tjreidy3@hotmail.com


'/>"/>
SOURCE KC Investor Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Adolor Corporation to Host Investor Conference Call to Report 2008 Financials and Provide an Update on the Launch of ENTEREG(R) (alvimopan)
2. Famed IT Investor and Director of 23andme Esther Dyson Identifies on IdeasProject.com Genetic Information as an Extremely Disruptive Force
3. BioMed Realty Trust Announces New Financing for Joint Venture With Prudential Real Estate Investors
4. GeoVax Update Provided at the BIO CEO & Investor Conference 2009
5. Transcept Pharmaceuticals to Present at 11th Annual BIO CEO & Investor Conference
6. In Analyst Interview, Cord Blood America Says Stem Cells Now Front and Center for Researchers and Investors
7. BioMS Medical to present at BIO CEO and Investor Conference
8. Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009
9. Orexigen(R) Therapeutics to Speak at BIO CEO & Investor Conference
10. NeurogesX to Present at 11th Annual BIO CEO & Investor Conference
11. Sunesis to Present at the 11th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... InferMed , s ... will augment Elsevier ... olutions suite   Elsevier , a world-leading ... announced today the acquisition of  InferMed , a ... InferMed,s Arezzo technology supports clinicians in choosing the most ...
(Date:7/1/2015)... , July 1, 2015  UCB, a ... ), a global leader in designing, transforming, and ... Innovation Award in recognition of their close collaboration ... in UCB,s global business services (GBS) finance organization. ... providers and clients that work together effectively to ...
(Date:6/30/2015)... , June 30, 2015 /PRNewswire/ - Resverlogix ... of common shares of Resverlogix have approved the ... Eastern Capital Limited of 5,600,000 units at a ... Placement"), each unit being comprised of one common ... aggregate proceeds of approximately CAD$15 million; and (ii) ...
(Date:6/30/2015)... , June 30, 2015  Juniper Pharmaceuticals, ... focused on developing therapeutics that address unmet medical ... George Elston will present at the ... Wednesday, July 8, 2015Time: , 4:45 PM EDTLocation: ... (live & archive): , www.juniperpharma.com, under  ,Investor, ...
Breaking Biology Technology:Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2
... Interleukin Genetics, Inc. (OTCQB: ILIU) announced today ... Thursday, November 10 at 4:30 p.m. (EST) to discuss the ... call, dial 877-324-1976 (domestic) or 631-291-4550 (international). The live Webcast ... the Investors section of Interleukin Genetics, Inc.,s Website at ...
... Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ), ... gastroenterology markets, today announced third quarter 2011 financial results. ... September 30, 2011, net revenue was $13.1 million, up from ... net revenue was driven by an increase in sales of ...
... NEW YORK, Nov. 3, 2011 Reportlinker.com announces ... in its catalogue: Global ... http://www.reportlinker.com/p0619270/Global-Biochip-Markets-Microarrays-and-Lab-on-a-Chip.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory INTRODUCTION  ... BCC,s goal for this study ...
Cached Biology Technology:Interleukin Genetics, Inc. Announces Conference Call to Discuss Third Quarter 2011 Results 2Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 2Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 3Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 4Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 5Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 6Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 7Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 8Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 9Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 10Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 11Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 12Global Biochip Markets: Microarrays and Lab-on-a-Chip 2Global Biochip Markets: Microarrays and Lab-on-a-Chip 3Global Biochip Markets: Microarrays and Lab-on-a-Chip 4Global Biochip Markets: Microarrays and Lab-on-a-Chip 5
(Date:6/23/2015)...   Valencell, a leader in performance ... recent study that illustrates its PerformTek biometric technology ... In a study conducted at Valencell,s Biometric Lab, ... Apple Watch against a chest strap – the ... The study demonstrated that Valencell,s biometric technology delivers ...
(Date:6/18/2015)... June 18, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market announces that its Wocket® ... on "Money on the Mark", scheduled to air on WABC ... June 20 th . The broadcast air- ... 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO Gino Pereira ...
(Date:6/17/2015)... SAN JOSE, Calif. , June 17, 2015 ... leader in human interface solutions, today announced that ... has adopted the Synaptics ® ClearPad ® ... family of display driver integrated circuits (DDICs) for ... Note Pro. By leveraging ClearPad for full in-cell ...
Breaking Biology News(10 mins):Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3
... early diagnosis and treatment of lung cancer are being presented ... in Lugano, Switzerland (1-3 May 2009). "Lung cancer is ... Europe. One of the reasons for this is that symptoms ... late in the course of the disease," said Prof Rudolf ...
... proteins, key building blocks of all organisms, they need ... assembling them. An Iowa State University researcher ... these instructions are located in a cell,s DNA. ... Biological Chemistry , Michael Shogren-Knaak, assistant professor in biochemistry, ...
... will be featured in 85 presentations, workshops, and ... largest meeting for pediatric clinical research in the country. ... Children,s National obesity expert Nazrat Mirza, MD ... successful program that targets childhood obesity in the Latino ...
Cached Biology News:Early detection of lung cancer: New data presented at multidisciplinary meeting 2Children's National experts present at Pediatric Academic Societies' Annual Meeting 2Children's National experts present at Pediatric Academic Societies' Annual Meeting 3
ID clarifier: non-treated with lid...
... a novel disposable spin filtration device especially ... lysates in plasmid purification procedures. , ... spin filtration device especially designed to aid ... purification procedures. The neutralized lysate is centrifuged ...
... Not treated (or medium binding) polystyrene ... binds biomolecules through passive interactions,• Is ... large molecules, such as antibodies, that ... interact with the surface,• Binding capacity ...
... polystyrene formulation , High antibody-binding surface improves ... , Plates are certified for performance ... , Eight-well strips fit snugly in the plate ... even if turned upside down ...
Biology Products: